Padma Islami Life Insurance LimitedPADMALIFECategory Z

News & announcements

• Tue, 27th October 2026 10:05 am
  Q3 Financials

  (Q3 Un-audited): As per life revenue account of the company for July to September, 2026, excess of total expenses including claims over total income (deficit) was BDT 42.39 million as against excess of total income over total expenses including claims (surplus) of BDT 4.93 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to September, 2026, (cont.)
• Tue, 27th October 2026 10:05 am
  Q3 Financials

  (Continuation news of PADMALIFE): excess of total expenses including claims over total income (deficit) was BDT 127.43 million as against excess of total expenses including claims over total income (deficit) of BDT 140.79 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT (3,320.56) million as on September 30, 2026 as against BDT (3,065.20) million as on September 30, 2025. (end)
• Thu, 15th October 2026 10:45 am
  Board Meeting schedule under LR 16(1)

  As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2026 at 2:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.
• Sun, 30th August 2026 10:04 am
  Q2 Financials

  (Continuation news of PADMALIFE): was BDT 85.10 million as against excess of total expenses including claims over total income (deficit) of BDT 150.92 million in the corresponding previous period of 2025. Accordingly, Balance of Life Insurance Fund was BDT (3,272.04) million as on June 30, 2026 as against BDT (3,077.14) million as on June 30, 2025. (end)
• Sun, 30th August 2026 10:04 am
  Q2 Financials

  (Q2 Un-audited): As per life revenue account of the company for April to June, 2026, excess of total expenses including claims over total income (deficit) was BDT 35.66 million as against excess of total expenses including claims over total income (deficit) of BDT 65.32 million in the corresponding previous period of 2025. Whereas as per life revenue account of the company for January to June, 2026, excess of total expenses including claims over total income (deficit) (cont.)
• Sun, 23rd August 2026 11:24 am
  Board Meeting schedule under LR 16(1)

  As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 27, 2026 at 2:30 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
• Thu, 30th July 2026 12:40 pm
  Spot News

  Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 02.08.2026 to 04.08.2026 and trading of the shares will remain suspended on record date i.e., 06.08.2026.
• Mon, 20th July 2026 04:12 pm
  Qualified Opinion

  The auditor of the company has given the Qualified Opinion paragraph in the auditor's report for the year ended December 31, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/PADMALIFE-2025.pdf
• Wed, 15th July 2026 10:05 am
  Dividend Declaration

  The Board of Directors has recommended No dividend for the year ended December 31, 2025. Date of AGM: 17.09.2026, Time: 11:00 AM, Venue: Physical presence at Padma Life Tower, (Top Floor) 115, Kazi Nazrul Islam Avenue, Banglamotor, Dhaka -1000. Record Date: 06.08.2026.
• Wed, 15th July 2026 10:05 am
  Price Limit Open

  There will be no price limit on the trading of the shares of the Company today (15.07.2026) following its corporate declaration.
• Wed, 15th July 2026 10:05 am
  Q1 Financials

  (Q1 Un-audited): As per life revenue account of the company, total income was Tk. 51,697,375 for January to March 2026 as against Tk. 23,290,078 for January to March 2025; total expenses was Tk. 94,939,790 for January to March 2026 as against Tk. 115,883,888 for January to March 2025. Balance of Life Insurance Fund was Tk. (3,236,375,268) as on March 31, 2026 as against Tk. (3,193,132,853) as on December 31, 2025.
• Sun, 5th July 2026 04:12 pm
  Reschedule of Board Meeting under LR 19(1)

  The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on July 14, 2026 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.
• Sun, 5th July 2026 04:12 pm
  Reschedule of Board Meeting under LR 16(1)

  The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on July 14, 2026 at 2:30 pm to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2026.
• Sun, 5th July 2026 11:45 am
  Postponement of Board Meeting schedule under LR 19(1)

  The Company has further informed that the meeting scheduled to be held on July 05, 2026 at 2:30 PM as per LR 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, audited financial statements for the year ended December 31, 2025 has been postponed. New date and time of the meeting will be notified later.
• Sun, 5th July 2026 11:45 am
  Postponement of Board Meeting schedule under LR 16(1)

  The Company has further informed that the meeting scheduled to be held on July 05, 2026 at 2:30 pm as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2026 has been postponed. New date and time of the meeting will be notified later.